Silver Book Fact

5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.

Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure. The American Journal of Medicine Web site. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14715324&dopt=Abstract. Published 2004

Reference

Title
Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure
Publication
The American Journal of Medicine
Publisher
Elsevier
Publication Date
Published 2004
Authors
Cowper, P.A., E. DeLong, D.J. Whellan, N.M. Allen LaPointe, and R.M. Califf
Volume & Issue
Volume 116, Issue 2
Pages
104-111
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The development of antioxidants that reduce oxidative damage is underway. One antioxidant that has been found, uric acid, has an even greater protective effect when combined with tPA.  
  • Greater use of clot-busting drug t-PA in ischemic stroke patients could save the health care system over $100 million a year.  
  • “Increasing life expectancy in western society is a result of two major success stories in the prevention and treatment of human disease. The first milestone was eliminating the scourge of…  
  • According to the National Center for Health Statistics, if all major forms of cardiovascular disease were eliminated, life expectancy would rise by close to 7 years.  
  • A major objective is to control blood pressure and preempt primary and secondary stroke. Assessing specific antihypertensive therapies will identify specific treatments that will lower blood pressure.